Find uplifting stories about heroes, innovations, and solutions
9094 results for "virus treatment"
Federal regulators just approved a groundbreaking melanoma treatment that transforms the herpes virus into a cancer-fighting weapon. For patients whose advanced skin cancer stopped responding to standard treatments, this innovative therapy offers new hope.
Scientists discovered how herpes viruses actively soften cell nuclei during infection, revealing a new target for fighting viral diseases. This breakthrough could lead to earlier diagnosis and more effective treatments for millions affected by viral infections.
A drug already approved for COVID-19 treatment just showed strong results against Nipah virus in early studies, potentially offering a faster path to fighting an infection that kills up to 75% of patients. The breakthrough could speed up treatment options since the drug is already approved for human use.
A single injection of an engineered virus is finally unlocking the immune system's power against glioblastoma, one of the deadliest brain cancers. Patients treated with the virus lived longer than expected, offering hope after 20 years without new treatment options.
A medication already being tested for hepatitis C shows promising results against hepatitis E, a deadly virus that kills 70,000 people yearly and has no approved treatment. Scientists discovered bemnifosbuvir stops the virus from replicating without harming healthy cells.
Researchers discovered how a vital protein acts as a "traffic controller" for our immune system and how a common virus learned to disable it. The breakthrough could lead to new treatments for autoimmune diseases by mimicking the virus's own tactics.
Researchers discovered how viruses like polio and the common cold switch on their copying machinery, revealing a promising target for new drugs that could fight multiple diseases at once. This breakthrough could lead to treatments that work against entire virus families instead of just one illness.
Scientists at Oregon Health & Science University have discovered a three-drug combination that completely eliminated HIV in newborn primates, offering hope for a cure instead of lifelong treatment. The breakthrough could transform care for 1.3 million children living with HIV worldwide.
A groundbreaking new HIV treatment offers people living with the virus a simpler, once-daily option that works differently from existing medications. The FDA just approved Idvynso, expanding choices for the 1.2 million Americans managing HIV.
Researchers have finally cracked the code on how Epstein-Barr virus leads to multiple sclerosis, opening the door to better treatments for the 2.9 million people living with the disease worldwide. The breakthrough also reveals why existing immunotherapy drugs work so well at slowing the condition.
After decades of managing HIV with complex multi-pill regimens, older patients may soon have access to a single daily pill that works just as well. A groundbreaking clinical trial shows the new treatment suppressed the virus in 96% of participants while also improving cholesterol levels.
A simpler HIV treatment just earned FDA approval, giving doctors a new option for patients managing the virus alongside other health conditions. The once-daily pill combines two drugs instead of three, offering hope for people juggling multiple medications.
A chance discovery in a Vermont lab just revealed that the two main flu viruses infect humans in completely different ways. This breakthrough could unlock new treatments that work better than anything we have today.
After years without any approved therapies, adults living with chronic hepatitis delta virus now have hope with the FDA's approval of Hepcludex, the first treatment for one of the most severe forms of viral hepatitis. This breakthrough fills a critical gap for nearly 200,000 Americans who face rapid progression to serious liver complications.
Scientists used a genetically modified herpes virus to help immune cells attack glioblastoma, the deadliest brain tumor. Patients in the trial lived longer than expected, offering new hope after 20 years without treatment advances.
A groundbreaking combination therapy has left nearly 9 in 10 hepatitis D patients with no detectable virus after two years of treatment. The results could transform care for a disease that often leads to liver failure within five years.
Scientists discovered that when HIV develops resistance to the groundbreaking drug lenacapavir, the virus loses its ability to spread effectively. This finding offers hope that the twice-yearly injection can remain a powerful tool in preventing and treating HIV.
Your body's cells have a secret weapon that destroys viruses and bacteria after they sneak past your immune system. Scientists just discovered how this hidden defense works, opening doors to new infection treatments.
A new HIV pill taken just once a week appears as effective as daily treatment in major studies. Over six million South Africans currently on daily HIV medication could benefit from simpler treatment.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
Showing 20 of 9094